Gene expression profile of human T cells following a single stimulation of peripheral blood mononuclear cells with anti-CD3 antibodies
Abstract Background Anti-CD3 immunotherapy was initially approved for clinical use for renal transplantation rejection prevention. Subsequently, new generations of anti-CD3 antibodies have entered clinical trials for a broader spectrum of therapeutic applications, including cancer and autoimmune dis...
Main Authors: | Isabel Garcia Sousa, Kelly Cristina Rodrigues Simi, Manuela Maragno do Almo, Maryani Andressa Gomes Bezerra, Gero Doose, Tainá Raiol, Peter F. Stadler, Steve Hoffmann, Andréa Queiroz Maranhão, Marcelo Macedo Brigido |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12864-019-5967-8 |
Similar Items
-
Current strategies for detecting functional convergence across B-cell receptor repertoires
by: Matthew I. J. Raybould, et al.
Published: (2021-01-01) -
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
by: Renato Kaylan Alves França, et al.
Published: (2023-09-01) -
Antibody-based cancer immunotherapy by targeting regulatory T cells
by: Quanxiao Li, et al.
Published: (2023-04-01) -
Antibody and transcription landscape in peripheral blood mononuclear cells of elderly adults over 70 years of age with third dose of COVID-19 BBIBP-CorV and ZF2001 booster vaccine
by: Yuwei Zhang, et al.
Published: (2024-01-01) -
REGULATORY CONSIDERATIONS OF BIOSIMILARS AND CLINICAL DILEMA OF THEIR USE
by: Sonja Genadieva Stavrik, et al.
Published: (2017-04-01)